HIF1A and inflammatory bowel disease: Though the review presents SCFAs’ regulatory effects on HIF-1α in IBD and their proven therapeutic value in experimental studies, clinical treatments designed to boost SCFAs synthesis in the body, like dietary fiber, probiotics, and polyphenols, fall short of expectations due to human physiological complexities.